Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

This program funds short-term exploratory clinical trials for arthritis, musculoskeletal, and skin conditions or diseases, including early-stage studies such as first-in-human, dose-finding, safety, and biomarker studies. Applicants may be higher education institutions, nonprofits, governments, tribes, faith-based or community-based organizations, regional organizations, foreign organizations, and other eligible entities, but non-domestic non-U.S. entities and non-domestic components of U.S. organizations are not eligible; foreign components are allowed. The combined direct-cost budget for three years may not exceed $600,000, with no more than $300,000 in direct costs in any single year, and the project period may be up to three years. No cost sharing is required.

✳ AI-generated summary — verify against the announcement

• Health
• Research & Discovery
• Patients & People with Health Conditions
• Biomedical & Disease Research

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments